Literature DB >> 19022961

3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells.

Sunyata Smith1, Daniel Sepkovic, H Leon Bradlow, Karen J Auborn.   

Abstract

Evidence suggests that 17beta-estradiol (E2) contributes to the risk of prostate cancer (PCa), whereas the phytochemicals genistein from soy and 3,3'-diindolylmethane (DIM), derived from indole-3-carbinol in cruciferous vegetables, decrease the risk of PCa. This study examined the potential of these phytochemicals to reduce the adverse effects of E2 on PCa. In LNCaP PCa cells (E2 sensitive), DIM decreased E2-induced proliferation. Genistein increased proliferation at low concentrations and decreased proliferation at higher concentrations; DIM abolished the increased proliferation by genistein. The E2 stimulation in LNCaP cells was consistent with dependence on the androgen receptor, as evidenced by the inhibition of E2-induced proliferation with the antiandrogen casodex, E2 stimulation of an androgen response element luciferase reporter, and E2 stimulation of prostate-specific antigen (PSA) protein expression. Both genistein and DIM abrogated the E2 stimulation of PSA. Genistein and DIM altered major E2 metabolism pathways in LNCaP and PC-3 (E2 insensitive) PCa cells by increasing the expression of the 2-hydoxylation enzyme cytochrome P450 1A1 (CYP1A1) and the O-methylating enzyme catechol-o-methyltransferase (COMT) as determined by real-time RT-PCR. The increase in COMT mRNA occurred only when the combination of DIM and genistein (15 micromol/L) was used. Quantitation by MS indicated increased 2-hydroxyestrogen and decreased 16alpha-hydroxyestrone, a result that should result in less estrogenicity and increased amounts of the anticancer metabolite 2-methoxyestrone. We conclude that DIM and genistein decrease the effects of E2 that have the potential to promote PCa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022961      PMCID: PMC3415863          DOI: 10.3945/jn.108.090993

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  58 in total

Review 1.  Estrogens and prostatic disease. International Prostate Health Council Study Group.

Authors:  K Griffiths
Journal:  Prostate       Date:  2000-10-01       Impact factor: 4.104

2.  Fruit and vegetable intakes and prostate cancer risk.

Authors:  J H Cohen; A R Kristal; J L Stanford
Journal:  J Natl Cancer Inst       Date:  2000-01-05       Impact factor: 13.506

Review 3.  Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent.

Authors:  H L Bradlow; D W Sepkovic; N T Telang; M P Osborne
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

4.  Ligand responsiveness in human prostate cancer: structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors.

Authors:  S McDonald; L Brive; D B Agus; H I Scher; K R Ely
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

5.  Estrone and estradiol metabolism in vivo in human breast cysts.

Authors:  U Raju; D W Sepkovic; W R Miller; J M Dixon; H L Bradlow; M Levitz
Journal:  Steroids       Date:  2000-12       Impact factor: 2.668

6.  Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.

Authors:  K M Lau; M LaSpina; J Long; S M Ho
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

7.  Androgen receptor and invasion in prostate cancer.

Authors:  Takahito Hara; Hideyo Miyazaki; Aram Lee; Chau P Tran; Robert E Reiter
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

Review 8.  Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.

Authors:  Shuk-Mei Ho
Journal:  J Cell Biochem       Date:  2004-02-15       Impact factor: 4.429

9.  Prospective study of fruit and vegetable intake and risk of prostate cancer.

Authors:  Victoria A Kirsh; Ulrike Peters; Susan T Mayne; Amy F Subar; Nilanjan Chatterjee; Christine C Johnson; Richard B Hayes
Journal:  J Natl Cancer Inst       Date:  2007-07-24       Impact factor: 13.506

10.  The specific role of isoflavones in reducing prostate cancer risk.

Authors:  Nagi B Kumar; Alan Cantor; Kathy Allen; Diane Riccardi; Karen Besterman-Dahan; John Seigne; Mohamad Helal; Raoul Salup; Julio Pow-Sang
Journal:  Prostate       Date:  2004-05-01       Impact factor: 4.104

View more
  9 in total

1.  Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey.

Authors:  Esther Walser-Domjan; Aline Richard; Monika Eichholzer; Elizabeth A Platz; Jakob Linseisen; Sabine Rohrmann
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

2.  Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.

Authors:  Shilpi Rajoria; Robert Suriano; Andrea George; Arulkumaran Shanmugam; Stimson P Schantz; Jan Geliebter; Raj K Tiwari
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

3.  The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes.

Authors:  Sabita N Saldanha; Trygve O Tollefsbol
Journal:  J Oncol       Date:  2011-12-07       Impact factor: 4.375

4.  Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia.

Authors:  William Weiben Zhang; Zhenqing Feng; Steven A Narod
Journal:  J Biomed Res       Date:  2014-04-20

5.  3,3'-Diindolylmethane Suppressed Cyprodinil-Induced Epithelial-Mesenchymal Transition and Metastatic-Related Behaviors of Human Endometrial Ishikawa Cells via an Estrogen Receptor-Dependent Pathway.

Authors:  Bo-Gyoung Kim; Jin-Wook Kim; Soo-Min Kim; Ryeo-Eun Go; Kyung-A Hwang; Kyung-Chul Choi
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

6.  Genistein Affects Expression of Cytochrome P450 (CYP450) Genes in Hepatocellular Carcinoma (HEPG2/C3A) Cell Line.

Authors:  Sandra R Lepri; Daniele Sartori; Simone C Semprebon; Adrivanio Baranoski; Giuliana C Coatti; Mario S Mantovani
Journal:  Drug Metab Lett       Date:  2018

7.  Diindolylmethane Derivatives: New Selective Blockers for T-Type Calcium Channels.

Authors:  Dan Wang; Pratik Neupane; Lotten Ragnarsson; Robert J Capon; Richard J Lewis
Journal:  Membranes (Basel)       Date:  2022-07-30

8.  Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).

Authors:  Mikhail Paltsev; Vsevolod Kiselev; Ekaterina Muyzhnek; Vadim Drukh; Igor Kuznetsov; Olga Pchelintseva
Journal:  EPMA J       Date:  2014-10-08       Impact factor: 6.543

9.  Sulforaphane Diminishes the Formation of Mammary Tumors in Rats Exposed to 17β-Estradiol.

Authors:  Dushani L Palliyaguru; Li Yang; Dionysios V Chartoumpekis; Stacy G Wendell; Marco Fazzari; John J Skoko; Yong Liao; Steffi Oesterreich; George K Michalopoulos; Thomas W Kensler
Journal:  Nutrients       Date:  2020-07-30       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.